Abstract:Background. Carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a threat to public health, most notably as a superbug causing nosocomial infections. Patients in the intensive care unit (ICU) are at increased risk of hospital-acquired K pneumoniae infection, especially CRKP. This study was conducted to investigate the frequency of gastrointestinal and nasopharyngeal K pneumoniae colonization and its contribution to infections in ICU patients.Methods. A 3-month prospective cohort study was performed in which 243 ICU patients were screened for intestinal and nasopharyngeal carriage of K pneumoniae at admission and once per week thereafter. The colonization and clinical infection isolates were analyzed by antimicrobial susceptibility testing to identify CRKP and were characterized by multilocus sequence typing (MLST) and whole-genome sequencing combined with epidemiological data to investigate the resistance mechanisms and assess the possible transmitted infection.Results. Twenty-eight percent (68 of 243) of patients tested positive for carriage of K pneumoniae immediately upon admission to ICU, 54% (37 of 68) of which were nonduplicate CRKP isolates. Patients with carbapenem-susceptible K pneumoniae (CSKP) colonization at admission were more likely to acquire CRKP colonization during the ICU stay compared with patients without K pneumoniae colonization at admission. The incidence of subsequent CRKP infection in the baseline CSKP (32.3%, 10 of 31) and CRKP (45.9%, 17 of 37) carrier group was significantly higher than that of the baseline non-KP carrier group (8.6%, 15 of 175). The risk factors associated with acquired CRKP colonization during the ICU stay among negative CRKP colonization at admission included previous exposure to carbapenem, tigecycline or beta-lactam/beta-lactamases inhibitor, and invasive processes or surgical operations. Sixty-four percent (27 of 42) of patients with K pneumoniae infection were colonized by clonally related K pneumoniae strains according to enterobacterial repetitive intergenic consensus sequence-polymerase chain reaction analysis. ST11 (72%, 53 of 74) was the most predominant MLST type of clonally related CRKP isolate colonizing these patients, followed by ST15 (26%, 19 of 74).Conclusions. The colonization of K pneumoniae may increase the incidence of corresponding K pneumoniae infection in critically ill patients in the ICU. High prevalence of ST11 CRKP (due to bla(KPC-2)) carriage and infection in ICU was observed.

Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection

Infections Caused by Carbapenemase-Producing Klebsiella Pneumoniae: Microbiological Characteristics and Risk Factors

Multidrug-resistant Klebsiella Pneumoniae-Induced Sepsis with Multiple Abscesses: A Case Report

A Retrospective Study Of Risk Factors For Carbapenem-Resistant Klebsiella Pneumoniae Acquisition Among Icu Patients

Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Klebsiella Pneumoniae Bloodstream Infections

Epidemiology and Virulence of Klebsiella pneumoniae

Klebsiella pneumoniae: an increasing threat to public health

Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae

Competitive Transmission of Carbapenem-Resistant Klebsiella Pneumoniae in a Newly Opened Intensive Care Unit

The Epidemiology, Virulence and Antimicrobial Resistance of Invasive Klebsiella Pneumoniae at a Children’s Medical Center in Eastern China

The Colonization Of Carbapenem-Resistant Klebsiella Pneumoniae: Epidemiology, Resistance Mechanisms, And Risk Factors In Patients Admitted To Intensive Care Units In China

Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors

Clinical Epidemiology of the Global Expansion of Klebsiella Pneumoniae Carbapenemases

Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A global public health threat

Klebsiella pneumoniae: Going on the Offense with a Strong Defense

Hypervirulent Klebsiella pneumoniae: Epidemiology, virulence factors, and antibiotic resistance

Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae

New Players to Combat Antibiotic Resistance in Klebsiella pneumoniae

Prevalence, Risk Factors, Treatment Outcome and Molecular Epidemiology of Gastrointestinal Carbapenem-Resistant Klebsiella Pneumoniae from Infections in China

Klebsiella pneumoniae infection biology: living to counteract host defences